Levetiracetam Desitin 500 mg/5 mL
Levetiracetam Desitin 500 mg/5 mL is a medicine authorised by Swissmedic under authorisation number 62616. The authorisation holder is Desitin Pharma GmbH. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 08 May 2012 and the authorisation is valid without a time limit. ATC code N03AX14 places the medicine in the group Antiepileptics.
| Authorisation number | 62616 |
|---|---|
| Name | Levetiracetam Desitin 500 mg/5 mL |
| Full name | Levetiracetam Desitin 500 mg/5 mL, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Desitin Pharma GmbH |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N03AX14 |
| First authorisation | 08 May 2012 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Levetiracetam Desitin 500 mg/5 mL, Konzentrat zur Herstellung einer Infusionslösung | B | 08 May 2012 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 10 | Ampulle(n) | N03AX14 | 01.07.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Levetiracetam Desitin 500 mg/5 mL authorised in Switzerland?
Yes. Levetiracetam Desitin 500 mg/5 mL is authorised by Swissmedic under authorisation number 62616, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Levetiracetam Desitin 500 mg/5 mL have?
Levetiracetam Desitin 500 mg/5 mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Levetiracetam Desitin 500 mg/5 mL?
The authorisation holder is Desitin Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.